BioSpace News Archive

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced top-line results from the Company’s ongoing open-label extension study, C602, evaluating investigational, once-daily DCCR Extended-Release tablets for patients with Prader-Willi syndrome and its comparison to data from the PATH for PWS natural history study.

Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced the appointment of Ali Hariri, M.D., as its Chief Medical Officer, overseeing clinical development efforts for the company’s promising pipeline of therapies to treat rare diseases.

Resverlogix Corp., a world leader in epigenetics, or gene regulation, announces that its investigational epigenetic therapeutic apabetalone met the primary endpoint in an investigator led pulmonary arterial hypertension pilot study, successfully completing the APPROACH-p trial.

Aruna Bio, Inc. today announced that Dr. Mark A. Sirgo , Chief Executive Officer, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13

Moleculin Biotech, Inc. today announced that Walter Klemp , President and Chief Executive Officer of Moleculin, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

Heska Corporation, a leading provider of advanced veterinary diagnostic and specialty healthcare products, announced the hire of Anthony Providenti to serve as Executive Vice President, Corporate Development.

Shoreline Biosciences, Inc. today announced that company management will present at the Wells Fargo 2021 Virtual Healthcare Conference, September 9 -10, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021.

Armata Pharmaceuticals, Inc. today announced that the Company will participate in the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a bioengineering company developing novel organ regeneration technology based its patented Cellframe™ and Cellspan™ technology, today announced the appointment of Jerry He as an independent director to its Board of Directors, adding strength in the areas of business innovation, strategy and finance.

Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to establish a manufacturing facility in Nashville dedicated to the production of single-use technologies products.